These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 24633004

  • 1. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y, Annagur BB, Sayin AA, Akbaba N.
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract] [Full Text] [Related]

  • 2. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J, Franks R, Roane D, Bayard M.
    J Am Board Fam Med; 2007 Jun; 20(5):499-502. PubMed ID: 17823470
    [Abstract] [Full Text] [Related]

  • 3. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
    Young L, Coffey BJ.
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
    [No Abstract] [Full Text] [Related]

  • 4. Risperidone, a risk factor for valproate-induced encephalopathy?
    Rodrigues-Silva N, Venâncio Â, Bouça J.
    Gen Hosp Psychiatry; 2013 Oct; 35(4):452.e5-6. PubMed ID: 23317937
    [Abstract] [Full Text] [Related]

  • 5. Ammonemia in bipolar patients on maintenance treatment with valproic acid.
    Bocchetta A, Siddu A, Sardu C, Sarnicola A, Martinelli V.
    J Clin Psychopharmacol; 2012 Feb; 32(1):148-50. PubMed ID: 22217957
    [No Abstract] [Full Text] [Related]

  • 6. A case of hyperammonemic encephalopathy after 11 years of valproate therapy.
    Stewart JT.
    J Clin Psychopharmacol; 2008 Jun; 28(3):361-2. PubMed ID: 18480705
    [No Abstract] [Full Text] [Related]

  • 7. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L, Hall Y, Schubert D.
    Int J Psychiatry Med; 2003 Jun; 33(1):91-6. PubMed ID: 12906346
    [Abstract] [Full Text] [Related]

  • 8. [Valproate-induced hyperammonemic encephalopathy. Review of cases in the psychiatric setting].
    Fassi G, Igoa A, Liste OA.
    Vertex; 2008 Jun; 19(82):371-7. PubMed ID: 19424520
    [Abstract] [Full Text] [Related]

  • 9. Decoding the enigma: Valproate encephalopathy in a bipolar affective disorder without hyperammonemia.
    Sousa BSGC, de Sá ZC, Ramos J.
    Bipolar Disord; 2024 Aug; 26(5):507-509. PubMed ID: 38825712
    [No Abstract] [Full Text] [Related]

  • 10. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
    Abreu LN, Issler C, Lafer B.
    Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
    [No Abstract] [Full Text] [Related]

  • 11. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting.
    Kimmel RJ, Irwin SA, Meyer JM.
    Int Clin Psychopharmacol; 2005 Jan; 20(1):57-8. PubMed ID: 15602119
    [Abstract] [Full Text] [Related]

  • 12. Valproate-induced hyperammonemic encephalopathy associated with urinary tract infection and urinary retention in the psychiatric setting.
    Dawson LP, Lee SJ, Hollander YS.
    Aust N Z J Psychiatry; 2016 Nov; 50(11):1110. PubMed ID: 27056174
    [No Abstract] [Full Text] [Related]

  • 13. Hyperammonemia induced by interaction of valproate and quetiapine.
    Halaby A, Haddad R, Naja WJ.
    Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
    [Abstract] [Full Text] [Related]

  • 14. Valproate induced hyperammonemic encephalopathy successfully treated with levocarnitine.
    Rigamonti A, Lauria G, Grimod G, Bianchi G, Salmaggi A.
    J Clin Neurosci; 2014 Apr; 21(4):690-1. PubMed ID: 24119342
    [Abstract] [Full Text] [Related]

  • 15. Valproate (VPA)-associated hyperammonemic encephalopathy independent of elevated serum VPA levels: 21 cases in China from May 2000 to May 2012.
    Cheng M, Tang X, Wen S, Yue J, Wang H.
    Compr Psychiatry; 2013 Jul; 54(5):562-7. PubMed ID: 23246073
    [Abstract] [Full Text] [Related]

  • 16. Lithium neurotoxicity at normal serum levels.
    Mesquita J, Cepa S, Silva L, Machado A.
    J Neuropsychiatry Clin Neurosci; 2010 Jul; 22(4):451-p.e29-451.e29. PubMed ID: 21037148
    [No Abstract] [Full Text] [Related]

  • 17. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure.
    Panda S, Radhakrishnan K.
    J Assoc Physicians India; 2004 Sep; 52():746-8. PubMed ID: 15839456
    [Abstract] [Full Text] [Related]

  • 18. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
    Patel N, Landry KB, Fargason RE, Birur B.
    Psychopharmacol Bull; 2017 Jan 26; 47(1):40-44. PubMed ID: 28138203
    [Abstract] [Full Text] [Related]

  • 19. Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient.
    Lin MW, Chang C, Yeh CB, Tai YM, Chang HA, Kao YC, Tzeng NS.
    Aust N Z J Psychiatry; 2017 Mar 26; 51(3):296-297. PubMed ID: 27694641
    [No Abstract] [Full Text] [Related]

  • 20. Lamotrigine might potentiate valproic acid-induced hyperammonemic encephalopathy.
    Fan CC, Huang MC, Liu HC.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct 01; 32(7):1747-8. PubMed ID: 18602440
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.